Ulcerative colitis (UC) is a chronic disease that causes inflammation in the large intestine, affecting between 600,000 and ...

Dual biologic therapy may serve as a suitable treatment choice for patients with IBD who have not responded to current therapies.

Inflammatory bowel disease is a diverse disease that affects people all over the globe. This diversity in setting and treatment options makes it difficult for researchers to estimate the exact cost of ...

According to the National Institutes of Health, between 600,000 and 900,000 Americans have ulcerative colitis, a chronic ...

There is insufficient evidence to support exclusive enteral nutrition as an adjunctive therapy for active ulcerative colitis, ...

Spyre Therapeutics' innovative combination therapy approach targets multiple inflammatory pathways. Learn why SYRE stock is a Buy.

Achieving cost sustainability in inflammatory bowel disease (IBD) care requires expanding access to cost-effective treatments ...

Nationally recognized pediatric gastroenterologist, Michael Dolinger, MD, MBA, joins Hassenfeld Children's Hospital at NYU Langone as director of the Pediatric Inflammatory Bowel Disease Program ...

Johnson & Johnson (NYSE:JNJ) recently experienced a 12% price increase over the last quarter, largely driven by significant ...